ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

ClinicalTrials.gov ID: NCT05248997

Public ClinicalTrials.gov record NCT05248997. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 5:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Chronic Rhinosinusitis (CRS) With or Without Nasal Polyps

Study identification

NCT ID
NCT05248997
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
261 participants

Conditions and interventions

Interventions

  • Matching placebo Drug
  • rimegepant 75 mg ODT Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2022
Primary completion
Mar 10, 2024
Completion
Apr 1, 2024
Last update posted
Mar 25, 2025

2022 – 2024

United States locations

U.S. sites
33
U.S. states
14
U.S. cities
27
Facility City State ZIP Site status
San Diego Clinical Research Center La Mesa California 91942
Velocity Clinical San Diego La Mesa California 91942
National Research Institute Panorama City California 91402
Sacramento Ear Nose and Throat Surgical and Medical Group, Inc. Roseville California 95628
Sharp & Children's MRI Center, LLC (CT scan) San Diego California 92123
Breathe Clear Institute Torrance California 90503
Colorado ENT & Allergy Colorado Springs Colorado 80923
Velocity Clinical Research, New Smyrna Beach Edgewater Florida 32132
The Medici Medical Research, LLC Hollywood Florida 33021
Avantis Clinical Research Miami Florida 33155
Clinovation Research Pompano Beach Florida 33064
Treasure Valley Medical Research Boise Idaho 83706
ChicagoENT Chicago Illinois 60657
Kentuckiana Ear, Nose & Throat Louisville Kentucky 40205
Best Clinical Trials, LLC (Administrative Only) New Orleans Louisiana 70115
George Stanley Walker, MD New Orleans Louisiana 70115
University of Missouri Hospital & Clinics, ENT & Allergy Center of Missouri Columbia Missouri 65201
University of Missouri Healthcare - Investigational Pharmacy Columbia Missouri 65212
University of Missouri Hospital (Radiology) Columbia Missouri 65212
Clinvest Research, LLC Springfield Missouri 65810
St Charles Clinical Research Weldon Spring Missouri 63304
Northwell Health Department of Otolaryngology New Hyde Park New York 11042
Tekton Research, Inc. Edmond Oklahoma 73013
Allergy, Asthma & Clinical Research Center Oklahoma City Oklahoma 73120
Vital Prospects Clinical Research Institute, P.C. Tulsa Oklahoma 74136
Velocity Clinical Research, Grants Pass Grants Pass Oregon 97527
Velocity Clinical Research, Medford Medford Oregon 97504
Velocity Clinical Research, Anderson Anderson South Carolina 29621
Carolina ENT Clinic/CENTRI Inc. Orangeburg South Carolina 29118
Spokane Ear, Nose & Throat/ Columbia Surgical Specialists Spokane Washington 99201
Principle Research Solutions Spokane Washington 99204
Spokane Ear, Nose & Throat / Columbia Surgical Specialists Spokane Washington 99216
Allergy, Asthma & Sinus Center, S.C. Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05248997, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2025 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05248997 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →